A novel AKR1C3 specific prodrug TH3424 with potent anti-tumor activity in liver cancer
- Type
- Retraction
- Notice date
- 12/4/2019 0:00
- Journal
- Clinical Pharmacology & Therapeutics
- Publisher
- American Society for Clinical Pharmacology and Therapeutics
- Notice DOI
- 10.1002/cpt.1708
- Original paper DOI
- 10.1002/cpt.2171